PHARM: Angina Flashcards
1
Q
Sx of angina and how can it be different in females?
A
- severe, crushing pain
- SOB lasting a few mins
- females often present w/ N&V, back/jaw pain, radiating to shoulder
2
Q
3 types of angina (in terms of relative plaque/thrombi load)
A
- stable: only on exertion, high plaque load only and no thrombi
- unstable: @ rest, some plaque and some thrombi formation
- variant (vasospastic) angina: no atherosclerosis, spasm of coronary artery
3
Q
3 main drug classes to treat angina
A
- nitrovasodilators (1st line)
- beta blockers (2nd line)
- DHP calcium channel blockers (3rd line, if B-blockers contraindicated)
4
Q
4 MECHANISMS to treat angina
A
- reduce contractility and heart rate = decreased oxygen demand AND increase coronary artery perfusion time = more sustained oxygen supply to the heart
- decrease TPR to decrease afterload
- reduce venous pressure to reduce preload/EDC
- dilate coronary arteries to increase perfusion to cardiac tissue
5
Q
inotropy, chronotropy, dromotropy
A
- inotropy = effect on contractility of heart
- chroNotropy = effect on SA node conduction and therefore HR
- dromotropy = effect on AV node conduction
6
Q
nitrovasodilators MOA, indications and example
A
- cause NO release in SMOOTH MUSCLE = increased cGMP = decreased Ca2+ = vasodilation
- reduces venous return, ultimately to decrease cardiac O2 demand
- independent of endothelium so can function if its damaged
- indications: angina (stable or unstable)
- e.g. nitroglycerin (GTN), isosorbide dinitrate
7
Q
contraindications and adverse effects of nitrovasodilators
A
- contraindicated w/ viagra (severe hypotension)
- AEs: hypotension, reflex tachycardia (therefore increased O2 consumption), headache (due to increased intracranial pressure), flushing, can develop tolerance after continual exposure
8
Q
how is GTN administered?
A
- sublingually
9
Q
what makes nitrovasodilators better than other vasodilators
A
- others only vasodilate the normal, functioning circuits = more blood flow to places that don’t need it
- nitros also vasodilate collateral circuits to perfuse evenly
10
Q
MOA and indications of B blockers
A
- blocks B1 receptors = decreased rate (-ve chronotrope) and force of contraction (-ve inotrope) = prevent arrhythmias
- leads to decreased BP (for HTN)
- decreased O2 consumption and increased coronary artery perfusion time (for HFrEF + angina)
- indications: HTN, HFrEF, angina, tachyarrhythmias
11
Q
adverse effects and contraindication of B blockers
A
- A/Es: cold extremities, bradycardia, bronchoconstriction
- contraindicated in asthma, UNSTABLE heart failure and with class IV anti-arrhythmics (non-DHP Ca2+ channel blockers)
12
Q
DHP Ca2+ channel blockers MOA + indications
A
- MOA: inhibit L-type Ca2+ channels in blood vessels = vasodilation = decreased afterload = decreased BP (for HTN) and decreased O2 consumption (for angina)
- indications: HTN, angina (stable + vasospastic)
13
Q
adverse effects and contraindications of DHP Ca2+ channel blockers
A
- AEs: cardiac depression, bradycardia, flushing, oedema, dizziness, headache, constipation, nausea
- C/I: heart failure and aortic stenosis